Uncompromised

Uncompromising

Independent Financial Advice Since 1974

Lowell, Blake & Associates is an independent employee-owned investment firm built for discerning investors who value a candid, unbiased and customized experience.

At LBA we’re beholden to no one but our clients. We answer to no corporate parent. We rely on no Wall Street research and avoid all conflicts of interest. Our fees are clear and fair.

In short, because our only purpose is to guide clients to important financial goals, we never compromise our principles and won’t ask you to.

Our fees and policies are transparent.

Our recommendations are based solely on unbiased in-house research. We sell no financial products. We answer only to our clients, not to sales quotas set by a corporate parent.

Clearly transparent

Every aspect of our business is an open book – from fees to investment philosophy to fiduciary level of care.

Proudly conflict-free

We rely solely on in-house investment research to avoid all bias and conflicts of interest.

Stubbornly independent

With no corporate parent to please, we’re fully focused on meeting the high expectations of our clients.

Perspectives

LBA Monthly View | November 2021

– Notable: Thanksgiving travel, semiconductor shortages, heating costs, shipping industry delays
– Company Highlights: Enterprise Products Partners, Novartis, Par Technology, Emerson, Canadian National Railway
– On our Minds: Inflations and Corporate Margins: A Thought Exercise

READ MORE

Reflections & Observations: Let’s Talk Inflation

In this newsletter edition we cover the following:
– Understanding the Yield Curve
– Enhancing Privacy and Security to Protect Against Identity Theft
– Inflation and Deflation: The Ongoing Tug-of-War Underpinning the Inflation Debate
– Managing Through Life Events
– The Fed’s Ongoing Yield Curve Control Is Becoming More Apparent
– Why Does October Spook Investors?

READ MORE

LBA Monthly View | September 2021

– Notable: NYC subway ridership, sugar & coffee production, high yield bond market
– Company Highlights: Enterprise Products, Visa, Novartis, Apple, Johnson & Johnson
– On Our Minds: The economic impacts of returning (or not returning) to work

READ MORE